Giovanni Roti

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations

Paolo Gorello, Giovanni Cazzaniga, Federica Alberti et al. · Leukemia · 2006 · 298 citations

Hematological Malignancy, Chromatin, Medicine +11

Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors

Miguel Aste-Amézaga, Ningyan Zhang, Janet Lineberger et al. · PLoS ONE · 2010 · 173 citations · Full text

Complementary Genomic Screens Identify SERCA as a Therapeutic Target in NOTCH1 Mutated Cancer

Giovanni Roti, Anne L. Carlton, Kenneth N. Ross et al. · Cancer Cell · 2013 · 148 citations · Full text

Tumor Biology, Somatic Variant, Medicine +8

Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

Yoshihiro Gocho, Jingjing Liu, Jianzhong Hu et al. · Nature Cancer · 2021 · 148 citations · Full text

Systems Pharmacology, Hematological Malignancy, Medicine +11

Selective HDAC1/HDAC2 Inhibitors Induce Neuroblastoma Differentiation

Stacey M. Frumm, Zi Peng Fan, Kenneth N. Ross et al. · Chemistry & Biology · 2013 · 112 citations · Full text

Medicine, Anti-cancer Agent, Tumor Suppressor +3